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with falling, vision impairments, and elbow, wrist or hand 
pain was associated with worse outcomes in most of the 
analyses. A broad range of specific comorbidities needs to 
be taken into account with the interpretation of patients’ 
health status after THA and TKA. More research includ-
ing the ascertainment of comorbidities preoperatively is 
needed, but it is conceivable that in particular, the presence 
of dizziness with falling, pain in other joints, and vision 
impairments should be assessed and treated in order to 
decrease the chance of an unfavorable outcome.
Keywords Osteoarthritis · Comorbidity · Surgery
Introduction
Total joint replacement surgery is a very effective treat-
ment option in the end stages of hip and knee osteoarthri-
tis (OA) [1]. By 2009, the numbers of patients undergoing 
total hip arthroplasty (THA) and total knee arthroplasty 
(TKA) have risen up to 1.6 and 1.2 per 1,000 per year in 
Abstract The aim of the study was to examine the rela-
tionship between comorbidities and pain, physical function 
and health-related quality of life (HRQoL) after total hip 
arthroplasty (THA) and total knee arthroplasty (TKA). A 
cross-sectional retrospective survey was conducted includ-
ing 19 specific comorbidities, administered in patients who 
underwent THA or TKA in the previous 7–22 months in 
one of 4 hospitals. Outcome measures included pain, physi-
cal functioning, and HRQoL. Of the 521 patients (281 THA 
and 240 TKA) included, 449 (86 %) had ≥1 comorbidities. 
The most frequently reported comorbidities (>15 %) were 
severe back pain; neck/shoulder pain; elbow, wrist or hand 
pain; hypertension; incontinence of urine; hearing impair-
ment; vision impairment; and cancer. Only the prevalence 
of cancer was significantly different between THA (n = 38; 
14 %) and TKA (n = 52; 22 %) (p = 0.01). The associa-
tions between a higher number of comorbidities and worse 
outcomes were stronger in THA than in TKA. In multivari-
ate analyses including all comorbidities with a prevalence 
of >5 %, in THA dizziness in combination with falling and 
severe back pain, and in TKA dizziness in combination 
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Western countries [2]. In the Netherlands, the annual num-
ber of THA and TKA is 50,000 [3]. These numbers are 
expected to further increase in the coming years, due to the 
aging society and the growing prevalence of obesity [3]. 
Although the outcomes of THA and TKA are in general 
favorable with respect to pain, daily activities, and health-
related quality of life (HRQoL), 7–34 % of patients are not 
satisfied with the result of surgery [4].
One of the factors being associated with a poor outcome 
after THA and TKA concerns the presence of comorbidity 
[5]. In patients with hip or knee OA in general, comorbid-
ity was found to be highly prevalent and affecting physi-
cal functioning and HRQoL [6–8]. Regarding the presence 
of comorbidity in patients with hip or knee OA undergo-
ing THA or TKA, any form of comorbidity was reported in 
73 % of 893 Finnish patients waiting for THA or TKA [9]. 
Concerning the prevalence of specific comorbidities, the 
rates in THA and TKA patients vary among recent studies: 
hypertension in 18–64 % [10–14]; heart failure in 6–32 % 
[12, 13, 15–17]; diabetes in 4–24 % [9–14, 16, 17]; chronic 
obstructive pulmonary disease (COPD) in 6–13 % [10, 11, 
16, 17]; and back pain in 31–37 % [12, 13, 15] of patients 
with THA and/or TKA.
With respect to the association of the number of comor-
bidities and the outcomes of THA and TKA, it was found 
that an increasing number of affected joints was associated 
with worse postsurgical pain, physical function, and mental 
health [15, 18] as well as HRQoL [18, 19]. With respect to 
the association of specific comorbidities and outcomes of 
THA and TKA, the presence of neck, ankle/feet/toes pain 
[17], back pain [20] and stroke [21] in TKA and hyperten-
sion [22] in THA, obesity [22], and heart disease [16, 17] 
in both THA and TKA was associated with a worse health 
status after surgery. In all of these studies, the outcomes 
were determined 1–5 years after surgery.
So far, the literature on the associations of comorbidity 
with outcome in patients with hip or knee OA undergoing 
THA or TKA often focused on one or a limited number of 
comorbidities [17, 20, 23]. In other publications, an aver-
age comorbidity score was provided [15, 18, 19, 24], which 
obscures the relationship between specific comorbidities 
and the patients’ health status. Moreover, regarding the 
outcomes of THA and TKA, pain and physical functioning 
rather than HRQoL were considered [15, 19].
In daily practice, orthopedic surgeons take the presence 
of comorbidity into account in their decision for surgery, in 
part by using the ASA (American Society of Anesthesiolo-
gists) classification to identify patients with an increased 
risk of death or surgical complications. This use of this 
classification is, however, not aiming to identify patients 
with an increased risk of a worse functional outcome [25]. 
In 2012, 65 % of the patients undergoing THA or TKA in 
the Netherlands were classified as ASA II (mild systemic 
disease) and 11 % as ASA III–IV (severe systemic disease 
with or without constant threat of life) [4]. These figures 
indicate that comorbidity, both systemic as well as affect-
ing specific organs, is often present in both THA and TKA 
patients and may influence postoperative outcomes. In 
addition to the ASA classification, the Charnley Classifica-
tion [26, 27] is often used; however, this system does not 
specify specific forms of comorbidity.
Given the lack of knowledge on the incidence and asso-
ciations of a wide range of specific comorbidities and 
health status after THA and TKA, the aim of this study was 
to determine the burden of comorbidities among patients 
who underwent THA and TKA and to evaluate the associa-
tion between comorbidities and pain, physical function and 
HRQoL one year after surgery.
Method
Study design
This study had a cross-sectional design. It was a part of 
multicenter survey concerning the use of physical therapy 
[28] among consecutive patients who underwent THA or 
TKA in 2011 in 4 hospitals (Leiden University Medical 
Center, Leiden; Rijnland Hospital, Leiderdorp; Groene 
Hart Hospital, Gouda; and Reinier de Graaf Hospital Delft, 
the Netherlands). The study was carried out from July to 
October 2012, with a minimum of 7 months and a maxi-
mum of 22 months after surgery. This study was set up as 
a survey to be completed once and therefore judged to fall 
outside the remit of the Dutch law on Medical Research 
Involving Human Subjects Act (WMO), and an exemption 
for medical ethical review was given by the Medical Ethi-
cal Committee of the Leiden University Medical Center 
after checking the precision of the protocol. The study 
was conducted in accordance with the Handbook for Good 
Clinical Research Practice of the World Health Organiza-
tion and Declaration of Helsinki principles [http://www.
wma.net/en/30publications/10policies/b3/].
Recruitment of patients
Patients diagnosed with hip or knee OA were eligible for 
the study if they were 18 years or older and underwent pri-
mary THA or TKA between January 1 and December 31, 
2011.
Exclusion criteria were surgery for diagnoses other than 
OA and revision surgery.
We aimed to obtain total number of 400 completed 
questionnaires (200 THA and 200 TKA). Anticipating a 
response rate of 40 %, we planned to invite 1,000 patients 
from 4 different hospitals. Selection was done by means 
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of hospital registries. All patients in whom the diagno-
sis primary THA or TKA was made between January 1 
and December 31, 2011 were first selected, subsequently, 
all patients with a diagnosis of hip or knee OA, and age 
18 years or older were identified. In hospital 1, all eligible 
persons were invited. In hospital 2, the survey was sent to 
all persons who were already participating in a prospective 
study and underwent surgery in 2011, whereas in hospi-
tals 3 and 4, all consecutive patients who underwent sur-
gery were invited, until the total number of 1,000 invited 
patients was reached.
In all 4 hospitals, the treating orthopedic surgeon sent a 
letter explaining the study and requesting the patient to par-
ticipate, together with an information leaflet, an informed 
consent form, the survey and a pre-stamped, pre-addressed 
envelope to all selected patients. After patients signed the 
informed consent form, they were included in the study. 
Because the questionnaires were completed anonymously, 
no information was obtained on the patients who did not 
respond.
Sociodemographic and personal characteristics
Sociodemographic characteristics included age (years), sex, 
level of education (low, medium and high), and marital sta-
tus (living alone, yes/no). In addition, patient’s height (cm) 
and weight (kg) were recorded (to calculate the Body Mass 
Index), as well as their smoking status (current smoker yes/
no).
Presence of comorbidities
Information on comorbidities was gathered with two 
questionnaires:
First, a comorbidity questionnaire developed by the 
Dutch Central Bureau of Statistics (CBS) [29] was used, 
asking for the presence or absence of 19 different comor-
bidities in the previous year, divided in three domains: 
Musculoskeletal comorbidities: severe back pain (including 
slipped disc); severe neck or shoulder pain; severe elbow, 
wrist or hand pain; other chronic rheumatic diseases; Non-
musculoskeletal comorbidities: asthma or COPD (Chronic 
Obstructive Pulmonary Disease); (severe) cardiac disorder 
or coronary disease; arteriosclerosis (abdomen or legs); 
hypertension; (consequences of) stroke; severe bowel disor-
der; diabetes mellitus; migraine; psoriasis; chronic eczema; 
cancer; incontinence of urine; Sensory impairments: hear-
ing impairments (group and face-to-face conversation); 
vision impairments (short and long distance); dizziness in 
combination with falling.
Secondly, we used the self-reported Charnley Classifica-
tion [26, 27], which consists of three categories: Patients 
are assigned to class A if they have single joint arthropathy 
and no significant medical comorbidity. Class B patients 
have one other joint in need of an arthroplasty, or an unsuc-
cessful or failing arthroplasty in another joint, while class 
C patients have multiple joints in need of arthroplasty, mul-
tiple failing arthroplasties, or significant medical or psy-
chological impairment.
Physical functioning, pain, and HRQoL
Information on current postoperative physical functioning 
was collected by means of the pain and physical function-
ing subscales of the Hip disability Osteoarthritis Outcome 
Score (HOOS) [30] and the Knee injury Osteoarthritis 
Outcome Score (KOOS) [31]. The pain subscale consists 
of 10 and 9 (different) items in the HOOS and KOOS, 
respectively, whereas the physical functioning subscale 
comprises the same 17 items regarding activities in daily 
life in both HOOS and KOOS. The score range is 0–100, 
with higher scores meaning less pain and better physical 
functioning.
Health-related quality of life (HRQoL) was measured 
with the Short Form-36 questionnaire (SF36) [32]. The 
SF36 contains 8 subscales (physical functioning; role 
limitations due to physical health problems; bodily pain; 
general health perceptions; vitality; social functioning; 
role limitations due to emotional problems; and gen-
eral mental health). Scores on the subscales were trans-
formed into two component scores: a mental and physical 
component summary score. By using data from a Dutch 
general population, norm-based scores (relative to an 
average score in the general population of 50) were cal-
culated [32]. For all subscale scores and summary scores, 
the score range was 0–100, with higher scores indicating 
a better health status.
Statistical analyses
Patients’ characteristics, the presence of different spe-
cific comorbidities, pain, physical functioning, and 
HRQoL were analyzed by using descriptive statistics. 
Differences between the characteristics of patients 
undergoing THA and TKA were examined by means 
of unpaired Students’ t test or Chi-square tests, where 
appropriate.
To study the relationship between the number of 
comorbidities and the four outcomes, multivariate regres-
sion models were employed. For this purpose, the num-
ber of comorbidities was categorized into four groups: 
1–2 comorbidities, 3–4 comorbidities, and 5 or more 
comorbidities, with 0 comorbidities being the reference 
group.
Then, all comorbidities (which occured in ≥5 of the 
patients) and potential confounders which were significantly 
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associated with the outcomes were included in final multi-
variate regression models.
All the analyses were corrected for BMI, whereas the 
analyses with pain and physical functioning as dependent 
variables were also adjusted for sex and age (SF36 scores 
were calculated using norm data so the correction for age 
and sex would be redundant).
All data were analyzed using the SPSS statistical 
package (version 20.0, SPSS, Chicago, Illinois). The 




In total 1,005 patients were requested to complete the sur-
vey in the 4 participating hospitals. Of these patients, 539 
(53.6 %) underwent THA and 466 (46.4 %) TKA. The 
response to the survey was 521 out of 1,005 (51.8 %) for 
the total group, with 281 out of 539 (52.1 %) patients 
responding in the THA and 240 out of 466 (51.5 %) in the 
TKA groups.
Table 1 shows the baseline characteristics of the study pop-
ulation. Two-thirds of the patients were female (65.2 %), their 
mean age was 70.0 (SD 9.3) years, and the mean BMI 27.8 
(SD 4.7), with the latter being significantly lower in the THA 
group as compared to the TKA group (26.7 (SD 4.1) and 29.2 
(SD 5.1), respectively (p < 0.001)). There were significantly 
more obese (BMI 30–40) patients in the TKA group than in 
the THA group (36.6 % and 17.9 %, respectively, p < 0.001), 
while no difference regarding the frequency of morbid obe-
sity (BMI > 40) was seen between THA and TKA.
The average pain and physical functioning scores as 
measured by the HOOS and KOOS, respectively, were sig-
nificantly higher in the THA group than in the TKA group 
(p = 0.010 and p = 0.014, respectively), whereas the SF36 
mental and physical component summary scales did not 
differ between THA and TKA.
In the group of patients who underwent THA, statisti-
cally significantly more patients were classified as Charn-
ley Class A and significantly less patients classified as 
Charnley Class C as compared to TKA (p = 0.004 and 
p = 0.006, respectively).
Concerning the occurrence of specific comorbidities, 
hypertension and hearing impairments in a group conver-
sation were the most frequently reported comorbidities 
Table 1  Characteristics of 521 patients who underwent total hip arthroplasty or total knee arthroplasty in 2011
All variables expressed as numbers (%), unless stated otherwise
* Statistical significant difference between total hip and total knee patients by means of a Student t test or Chi-square test where appropriate
Variable All patients (N = 521) Total hip (N = 281) Total knee (N = 240) p value
Sex, female (N = 515) 336 (65.2 %) 178 (64.0 %) 158 (66.7 %) 0.53
Age, years (mean, SD) 70.0 (9.3) 69.8 (9.5) 70.1 (9.0) 0.69
Body Mass Index (BMI) (mean, SD) (N = 508) 27.8 (4.7) 26.7 (4.1) 29.2 (5.1) <0.001*
BMI < 25 150 (29.5 %) 100 (36.6 %) 50 (21.3 %) <0.001*
BMI 25–30 (overweight) 217 (42.7 %) 123 (45.1 % 94 (40.0 %) 0.25
BMI 30–40 (obesity) 135 (26.6 %) 49 (17.9 %) 86 (36.6 %) <0.001*
BMI > 40 (morbid obesity) 6 (1.2 %) 1 (0.4 %) 5 (2.1 %) 0.07
Current smoker (N = 507) 44 (8.7 %) 29 (10.5 %) 15 (6.5 %) 0.11
Education level (N = 400)
 Low 160 (40.0 %) 82 (38.5 %) 78 (41.7 %) 0.51
 Medium 151 (37.8 %) 76 (35.7 %) 75 (40.1 %) 0.36
 High 89 (22.2 %) 55 (25.8 %) 34 (18.2 %) 0.07
 Marital status, living alone (N = 365) 109 (29.9 %) 55 (28.8 %) 54 (31.0 %) 0.64
 HOOS or KOOS pain; mean (SD) 81.7 (19.1) 84.0 (17.1) 79.0 (20.9) 0.010*
 HOOS or KOOS physical functioning; mean (SD) 78.9 (20.9) 81.3 (18.9) 76.1 (22.7) 0.014*
 SF36 physical component summary scale; mean (SD) 45.4 (8.6) 45.6 (8.9) 45.2 (8.2) 0.61
 SF36 mental component summary scale; mean (SD) 47.7 (7.7) 48.0 (7.6) 47.5 (7.8) 0.53
Charnley Classification (N = 505)
 Class A 125 (24.8 %) 81(29.9 %) 44 (18.8 %) 0.004*
 Class B 102 (19.6 %) 56 (19.9 %) 46 (19.2 %) 0.78
 Class C 278 (55.0 %) 134 (49.4 %) 144 (61.5 %) 0.006*
1237Rheumatol Int (2015) 35:1233–1241 
1 3
(>25 % for the total group). Severe back pain; severe neck/
shoulder pain; severe elbow, wrist or hand pain; cancer; 
incontinence of urine; and vision impairment short dis-
tances were reported by 15–25 % of the patients in the total 
group (Table 2).
The occurrence of cancer was significantly lower in 
the THA group than in the TKA group [38 (13.5 %) and 
52 (21.7 %), respectively (p = 0.01)]. Regarding all other 
specific comorbidities, there were no differences between 
THA and TKA (Table 2).
Table 2 also shows the distribution of the numbers of 
comorbidities in the total group and the THA and TKA 
groups. Overall, 86.2 % of the patients had one or more 
comorbidities. The proportion of patients with 5 or more 
comorbidities was higher in patients with TKA as com-
pared to THA [47 (19.6 %) and 37 (13.2 %), respectively 
(p = 0.047)].
Associations of the number of specific comorbidities 
with pain, physical functioning, and HRQoL
Table 3 shows that in THA, and adjusted for age, sex 
and BMI, where appropriate, the presence of 1 or 2 
comorbidities was significantly associated with worse 
physical functioning relative to no comorbidities. The 
presence of 3 or 4, and ≥5 comorbidities was associ-
ated with more pain, worse physical functioning, and a 
worse score on the physical component summary scale 
of the SF 36.
Table 3 shows that in TKA, only the presence of ≥5 
comorbidities was associated with a worse score regarding 
the physical component summary scale of the SF 36.
The presence of all the 19 specific comorbidities, except 
hypertension, was associated with one or more of the out-
comes in both THA and TKA (results not shown).
Table 2  Comorbidities in 521 patients who underwent total hip arthroplasty or total knee arthroplasty in 2011
* Statistical significant difference between total hip and total knee patients by means of a Chi-square test
Variable All patients (N = 521) Total hip (N = 281) Total knee (N = 240) p value
Musculoskeletal comorbidities
 Severe back pain (hernia included) 97 (18.6 %) 46 (16.4 %) 51 (21.3 %) 0.15
 Severe neck/shoulder pain 101 (19.4 %) 50 (17.8 %) 51 (21.2 %) 0.32
 Severe elbow, wrist or hand pain 86 (16.5 %) 43 (15.3 %) 43 (17.9 %) 0.42
 Other rheumatic diseases 65 (12.5 %) 30 (10.7 %) 35 (14.6 %) 0.18
Non-musculoskeletal comorbidities
 Asthma or COPD 59 (11.3 %) 29 (10.3 %) 30 (12.5 %) 0.43
 (Severe) cardiac disorder or coronary disease 55 (10.6 %) 31 (11.0 %) 24 (10.0 %) 0.70
 Arteriosclerosis in abdomen and legs 32 (6.1 %) 18 (6.4 %) 14 (5.8 %) 0.79
 Hypertension 220 (42.2 %) 108 (38.4 %) 112 (46.7 %) 0.06
 (Consequences) of a stroke 31 (6.0 %) 14 (5.0 %) 17 (7.1 %) 0.31
 Severe bowel disorder 23 (4.4 %) 10 (3.6 %) 13 (5.4 %) 0.30
 Diabetes Mellitus 70 (13.4 %) 31 (11.0 %) 39 (16.2 %) 0.08
 Migraine 33 (6.3 %) 16 (5.7 %) 17 (7.1 %) 0.52
 Psoriasis 16 (3.1 %) 9 (3.2 %) 7 (2.9 %) 0.85
 Severe eczema 21 (4.0 %) 12 (4.3 %) 9 (3.8 %) 0.76
 Cancer 90 (17.3 %) 38 (13.5 %) 52 (21.7 %) 0.01*
 Incontinence of urine 96 (18.4 %) 53 (18.9 %) 43 (17.9 %) 0.78
Sensory impairments
 Hearing impairments (group conversation) 139 (26.7 %) 68 (24.2 %) 71 (29.6 %) 0.17
 Hearing impairments (face-to-face conversation) 20 (3.8 %) 9 (3.2 %) 11 (4.6 %) 0.41
 Vision impairments (short distances) 94 (18.0 %) 52 (18.5 %) 42 (17.5 %) 0.77
 Vision impairments (long distances) 45 (8.6 %) 30 (10.7 %) 15 (6.2 %) 0.07
 Dizziness in combination with falling 32 (6.1 %) 15 (5.3 %) 17 (7.1 %) 0.41
Number of comorbidities
 0 72 (13.8 %) 45 (16.0 %) 27 (11.2 %) 0.12
 1 or 2 232 (44.5 %) 130 (46.3 %) 102 (42.5 %) 0.39
 3 or 4 133 (25.6 %) 69 (24.5 %) 64 (26.7 %) 0.58
 ≥5 84 (16.1 %) 37 (13.2 %) 47 (19.6 %) 0.047*
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Multivariate regression models with all comorbidities 
and pain, physical functioning, and HRQoL
Table 4 shows the results of the final multivariate regres-
sion models for worse outcome in THA for all four out-
comes. Comorbidities included in 3 out of 4 of the asso-
ciation models were dizziness in combination with 
falling and severe back pain (associated with more pain 
and worse physical functioning and physical component 
of HRQoL). Comorbidities included in 2 out of 4 of the 
models were severe back pain and arteriosclerosis in abdo-
men or legs (associated with more pain and worse physical 
functioning).
In Table 5, the results for TKA are shown. Vision 
impairments (long distances) were included in 3 out of 4 
of the association models and associated with more pain 
and worse physical functioning and mental component of 
HRQoL. Comorbidities included in two out of four asso-
ciation models were dizziness in combination with falling 
(associated with more pain and worse physical functioning) 
and severe elbow, wrist or hand pain (associated with worse 
physical functioning and physical component of HRQoL).
Discussion
This study in patients who underwent THA or TKA showed 
the presence of considerable amount of comorbidities in 
patients after surgery. Hypertension and hearing impair-
ments in a group conversation had the highest occurrence 
rates (>25 %), while severe back pain; neck/shoulder pain; 
elbow, wrist or hand pain; cancer; and vision impairments 
regarding short distances were also relatively frequent, as 
they were reported by 15–20 % of the patients.
Some of the present frequencies of the occurrence of 
specific comorbidities in this study were comparable with 
earlier studies, i.e., hypertension (42 % in THA [13] and 
42 % in TKA [12]); heart disease (7 % in THA [16] and 
8 % in TKA [10]); diabetes (10 % in THA [13] and 11 % in 
TKA [12]); and COPD (9 % in THA [16] and 10 % in TKA 
[10, 12]).
The rate of the presence of back pain in the present 
study was somewhat lower than in earlier studies (37 % 
in THA [13] and 31–35 % in TKA [12, 17]), probably 
due to the fact that we asked for severe back pain only. 
In general, comparisons of rates with previous studies 
are hampered by the differences in time lapse between 
surgery and the measurement of comorbidities and 
outcomes.
In our study, an increasing number of comorbidities 
was associated with worse pain and physical function, 
and reduced quality of life. This observation appeared to 
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was also seen for HRQOL and/or or physical functioning 
in studies by Rat et al. [19] and Stevens et al. [18], concern-
ing THA and TKA plus THA, respectively. Perrucio et al. 
[15] reported more pain and worse physical functioning 
with increasing joint counts in patients after TKA. This is 
in some extent comparable with our study, in which mul-
tiple sites of joint involvement were included as specific 
comorbidities. However, no good comparisons can be made 
since no specified analyses for other impaired joints were 
conducted in our study.
The present study focused on 19 different comorbidities. 
From models including all comorbidities, it appeared that 
in THA, dizziness with falling and severe back pain were 
associated with 3 out of 4 outcomes, while in TKA, dizzi-
ness with falling and vision impairments (long distances) 
were associated with 2 out of 4 outcomes.
The presence of dizziness in combination with falling 
is difficult to compare with other studies, as these studies 
did not include this comorbidity. Dizziness has, however, 
been previously identified as one of the main reasons for 
a longer stay in hospital after surgery [33] and can be 
related to presence of anemia, which is related to worse 
outcome in hip fracture patients [15]. In our study, severe 
back pain was also consistently associated with worse pain 
and physical function, and reduced quality of life in THA. 
This finding is in contrast with the results from the study 
by Novicoff et al. [20] in which this association was found 
in TKA.
In our study, obesity was not considered as a specific 
comorbidity, but rather as an influential factor. There-
fore, BMI was included in all analyses. The literature 
shows conflicting evidence regarding the association of 
obesity with complications after surgery [34]. Regard-
ing physical functioning, however, there seems to be 
no difference in outcome between obese and non-obese 
patients. Only morbidly obese patients (BMI > 40) were 
found to be at a greater risk for perioperative complica-
tions such as infection and revision than patients with a 
BMI < 40, most likely due to the additional other exist-
ing comorbidities (i.e., diabetes, hypertension, and car-
diac diseases) [35]. On the other hand, obesity can be 
considered as a contraindication by orthopedic surgeons 
in their decision for surgery, based on the ASA criteria, 
thereby leading to a probable underestimation of their 
influence on postsurgical outcome. It remains unclear to 
what extent this occurred in our study, as the frequency 
of morbid obesity (BMI > 40) was only 1 % in our study 
population.
This study has a number of limitations. First, only 4 hos-
pitals in a specific area in the Netherlands were involved, 
the sample size was limited and varied between sites, the 
response rate was moderate (52 %), and no comparison of 
the characteristics of the participants and non-responders 
could be made. Therefore, results cannot be generalized 
to all patients undergoing THA or TKA. However, based 
on baseline characteristics, it seems to be a representa-
tive sample of this patient group. Furthermore, the study 
is cross-sectional and not longitudinal, which makes that 
only associations can be determined, and no predictions 
can be made. Preferably, data on the presence of comor-
bidity should be gathered preoperatively. Moreover, the 
assessments only included self-reported questionnaires. 
Examination of the medical records could probably have 
given more reliable and additional information; however, 
this very time-consuming method could not be used in the 
framework of this study.
Despite these limitations, this study taking a large 
number of comorbidities into consideration and analyz-
ing THA and TKA patients separately found that not 
only the number of comorbidities but also their nature 
are related to the outcomes. In particular, dizziness 
Table 4  Comorbidities included in the final multivariate regression 
models of the association of comorbidity with pain, physical func-
tioning, and health-related quality of life in 281 patients undergoing 
THA
a
 Statistical analyses adjusted for age, sex, and BMI
b
 Statistical analyses adjusted for BMI
B (95 % CI) p value R2
HOOS/KOOS subscale paina
 Arteriosclerosis in abdomen 
or legs
−12.3 (−21.7; −2.9) 0.010 0.147
 Dizziness in combination 
with falling
−12.1 (−23.5; −0.7) 0.037
 Cardiac disorders −10.6 (−17.6; −3.6) 0.003
 Severe back pain −8.0 (−14.0; −2.0) 0.009
 Cancer −6.7 (−12.6; −0.7) 0.028
HOOS/KOOS subscale physical functioninga
 Dizziness in combination 
with falling
−22.0 (−34.2; −9.9) <0.001 0.215
 Arteriosclerosis in abdomen 
or legs
−14.9 (−25.3; −4.5) 0.005
 Severe back pain −12.9 (−19.3; −6.4) <0.001
 Asthma or COPD −9.0 (−16.8; −1.3) 0.023
 Cancer −8.0 (−14.3; −1.7) 0.013
SF36 physical component scaleb
 Dizziness in combination 
with falling
−6.4 (12.5; −0.4) 0.037 0.094
 Severe back pain −3.5 (−6.6; −0.4) 0.028
Incontinence of urine −3.2 (−6.4; −0.1) 0.045
Hypertension −2.9 (−5.3; −0.5) 0.017
SF36 mental component scaleb
 (Consequences of) a stroke −4.8 (−9.0; −0.6) 0.024 0.044
 Severe elbow, wrist or hand 
pain
−3.2 (−6.2; −0.3) 0.032
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in combination with falling plays a consistent role in 
both THA and TKA, and severe low back pain in THA. 
Although a prospective study including the presence of 
a wide range of comorbidities preoperatively is needed, 
the results of the present study suggest that a large num-
ber of specific comorbidities have an impact on patients’ 
health status after surgery. As many comorbidities are 
chronic by nature and therefore likely to have been pre-
sent before surgery as well, their presence should prob-
ably be ascertained before surgery and treated if possible, 
since the predictive value is confirmed in earlier studies 
[36]. Although not yet confirmed in a prospective study, 
in particular, the presence of dizziness in combination 
with falling should probably be taken into account before 
surgery.
Currently, the ASA classification [25] is used pre-
operatively, but this is mainly aimed at the selection 
of patients regarding their risk to undergo surgery, 
and not with respect to their risk of adverse func-
tional outcomes. With respect to the latter, the Charn-
ley Classification is a commonly used instrument 
[26, 27], but it does not distinguish clearly between 
specific conditions. Detecting the presence of more 
specific comorbidities seems to be of additional 
value.
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